Artiva Biotherapeutics (ARTV) Equity Ratio (2023 - 2025)
Historic Equity Ratio for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to 0.87.
- Artiva Biotherapeutics' Equity Ratio fell 256.76% to 0.87 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.87, marking a year-over-year decrease of 256.76%. This contributed to the annual value of 0.89 for FY2024, which is 15777.77% up from last year.
- Artiva Biotherapeutics' Equity Ratio amounted to 0.87 in Q3 2025, which was down 256.76% from 0.88 recorded in Q2 2025.
- In the past 5 years, Artiva Biotherapeutics' Equity Ratio registered a high of 0.89 during Q3 2024, and its lowest value of 2.52 during Q2 2024.
- For the 3-year period, Artiva Biotherapeutics' Equity Ratio averaged around 0.05, with its median value being 0.88 (2025).
- In the last 5 years, Artiva Biotherapeutics' Equity Ratio skyrocketed by 15777.77% in 2024 and then plummeted by 256.76% in 2025.
- Quarter analysis of 3 years shows Artiva Biotherapeutics' Equity Ratio stood at 1.54 in 2023, then surged by 157.78% to 0.89 in 2024, then dropped by 2.52% to 0.87 in 2025.
- Its Equity Ratio was 0.87 in Q3 2025, compared to 0.88 in Q2 2025 and 0.88 in Q1 2025.